Nanotechnologies for Cellular and Molecular Imaging by MRI

Nanofabrication Towards Biomedical Applications: Techniques, Tools, Applications, and Impact

Volumn , Issue , 2005, Pages 227-249

  Winter, Patrick M ^a   Caruthers, Shelton D ^a,b   Wickline, Samuel A ^a   Lanza, Gregory M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Biomedical applications; Cardiovascular disease; Cellular and molecular imaging by MRI; Characterization tools; Iron oxides; Nanofabrication; Nanomaterials and nanosystems; Paramagnetic nanoparticles

Indexed keywords

EID: 84890629861     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603476.ch9     Document Type: Chapter

References (80)

1. S. H. Britz-Cunningham, S. J. Adelstein, Molecular targeting with radionuclides: state of the science. J. Nucl. Med. 2003, 44, 1945-1961.
2. H. R. Herschman, Molecular imaging: looking at problems, seeing solutions. Science 2003, 302, 605-608.
3. R. Y. Tsien, Imagining imaging's future. Nat. Rev. Mol. Cell Biol. 2003, Suppl. pp. 16-21.
4. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr. Probl. Cardiol. 2003, 28, 625-653.
5. S. A. Wickline, G. M. Lanza, Molecular imaging, targeted therapeutics, and nanoscience. J. Cell Biochem. Suppl. 2002, 39, 90-97.
6. S. A. Wickline, G. M. Lanza, Nanotechnology for molecular imaging and targeted therapy. Circulation 2003, 107, 1092-1095.
7. L. Kostakoglu, H. Agress, S. J. Goldsmith Jr., Clinical role of FDG PET in evaluation of cancer patients. Radiographics 2003, 23, 315-40; quiz 533.
8. K. Herholz, PET studies in dementia. Ann. Nucl. Med. 2003, 17, 79-89.
9. D. Kwekkeboom, E. P. Krenning, M. de Jong, Peptide receptor imaging and therapy. J. Nucl. Med. 2000, 41, 1704-1713.
10. F. G. Blankenberg, H. W. Strauss, Noninvasive strategies to image cardiovascular apoptosis. Cardiol. Clin. 2001, 19, 165-172, x.
11. F. M. Bengel, M. Anton, N. Avril, T. Brill, N. Nguyen, R. Haubner, E. Gleiter, B. Gansbacher, M. Schwaiger, Uptake of radiolabeled 2¢-fluoro-2¢-deoxy-5-iodo-1-beta-d-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation 2000, 102, 948-950.
12. G. M. Lanza, K. D. Wallace, M. J. Scott, W. P. Cacheris, D. R. Abendschein, D. H. Christy, A. M. Sharkey, J. G. Miller, P. J. Gaffney, S. A. Wickline, A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996, 94, 3334-3340.
13. G. M. Lanza, K. D. Wallace, S. E. Fischer, D. H. Christy, M. J. Scott, R. L. Trousil, W. P. Cacheris, J. G. Miller, P. J. Gaffney, S. A. Wickline, High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med. Biol. 1997, 23, 863-870.
14. G. M. Lanza, R. L. Trousil, K. D. Wallace, J. H. Rose, C. S. Hall, M. J. Scott, J. G. Miller, P. R. Eisenberg, P. J. Gaffney, S. A. Wickline, In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J. Acoust. Soc. Am. 1998, 104, 3665-3672.
15. G. M. Lanza, D. R. Abendschein, C. S. Hall, J. N. Marsh, M. J. Scott, D. E. Scherrer, S. A. Wickline, Molecular imaging of stretchinduced tissue factor expression in carotid arteries with intravascular ultrasound. Invest. Radiol. 2000, 35, 227-234.
16. G. M. Lanza, D. R. Abendschein, C. S. Hall, M. J. Scott, D. E. Scherrer, A. Houseman, J. G. Miller, S. A. Wickline. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J. Am. Soc. Echocardiogr. 2000, 13, 608-614.
17. A. L. Klibanov, M. S. Hughes, J. N. Marsh, C. S. Hall, J. G. Miller, J. H. Wible, G. H. Brandenburger, Targeting of ultrasound contrast material. An in vitro feasibility study. Acta Radiol. Suppl. 1997, 412, 113-120.
18. E. C. Unger, T. P. McCreery, R. H. Sweitzer, D. Shen, G. Wu, In vitro studies of a new thrombus-specific ultrasound contrast agent. Am. J. Cardiol. 1998, 81, 58G-61G.
19. S. M. Demos, H. Onyuksel, J. Gilbert, S. I. Roth, B. Kane, P. Jungblut, J. V. Pinto, D. D. McPherson, M. E. Klegerman, In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. J. Pharm. Sci. 1997, 86, 167-171.
20. S. M. Demos, H. Alkan-Onyuksel, B. J. Kane, K. Ramani, A. Nagaraj, R. Greene, M. Klegerman, D. D. McPherson, In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J. Am. Coll. Cardiol. 1999, 33, 867-875.
21. M. Takeuchi, K. Ogunyankin, N. G. Pandian, T. P. McCreery, R. H. Sweitzer, V. E. Caldwell, E. C. Unger, E. Avelar, M. Sheahan, R. Connolly, Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J. Am. Soc. Echocardiogr. 1999, 12, 1015-1021.
22. H. Gupta, R. Weissleder, Targeted contrast agents in MR imaging. Magn. Reson. Imaging Clin. North Am. 1996, 4, 171-184.
23. R. Weissleder, Molecular imaging: exploring the next frontier. Radiology 1999, 212, 609-614.
24. D. Artemov, Molecular magnetic resonance imaging with targeted contrast agents. J. Cell Biochem. 2003, 90, 518-524.
25. S. Flacke, S. Fischer,M. J. Scott, R. J. Fuhrhop, J. S. Allen, M. McLean, P. Winter, G. A. Sicard, P. J. Gaffney, S. A. Wickline, G. M. Lanza, Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104, 1280-1285.
26. G. M. Lanza, C. H. Lorenz, S. E. Fischer, M. J. Scott, W. P. Cacheris, R. J. Kaufmann, P. J. Gaffney, S. A. Wickline, Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. Acad. Radiol. 1998, 5 Suppl 1, S173-6; discussion S183-184.
27. P. M. Winter, S. D. Caruthers, X. Yu, S. K. Song, J. Chen, B. Miller, J. W. Bulte, J. D. Robertson, P. J. Gaffney, S. A. Wickline, G. M. Lanza. Improved molecular imaging contrast agent for detection of human thrombus. Magn. Reson. Med. 2003, 50, 411-416.
28. X. Yu, S. K. Song, J. Chen, M. J. Scott, R. J. Fuhrhop, C. S. Hall, P. J. Gaffney, S. A. Wickline, G. M. Lanza, High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 2000, 44, 867-872.
29. H. W. Kang, L. Josephson, A. Petrovsky, R. Weissleder, A. Bogdanov Jr., Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug. Chem. 2002, 13, 122-127.
30. S. D. Tiukinhoy, M. E. Mahowald, V. P. Shively, A. Nagaraj, B. J. Kane, M. E. Klegerman, R. C. MacDonald, D. D. McPherson, J. S. Matsumura, Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Invest. Radiol. 2000, 35, 732-738.
31. J. R. Lindner, J. Song, J. Christiansen, A. L. Klibanov, F. Xu, K. Ley, Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001, 104, 2107-2112.
32. J. Chen, C. H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, R. Weissleder, In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002, 105, 2766-2771.
33. P. M. Winter, A. M. Morawski, S. D. Caruthers, R. W. Fuhrhop, H. Zhang, T. A. Williams, J. S. Allen, E. K. Lacy, J. D. Robertson, G. M. Lanza, S. A. Wickline, Molecular imaging of angiogenesis in earlystage atherosclerosis with amb3-integrin-targeted nanoparticles. Circulation 2003, 108, 2270-2274.
34. Z. J. Zheng, J. B. Croft, W. H. Giles, G. A. Mensah, Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001, 104, 2158-2163.
35. C. Napoli, C. K. Glass, J. L. Witztum, R. Deutsch, F. P. D'Armiento, W. Palinski, Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999, 354, 1234-1241.
36. A. W. Zieske, G. T. Malcom, J. P. Strong, Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr. Pathol. Mol. Med. 2002, 21, 213-237.
37. M. J. Davies, A. C. Thomas, Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 1985, 53, 363-373.
38. M. J. Davies, D. M. Krikler, D. Katz, Atherosclerosis: inhibition of regression as therapeutic possibilities. Br. Heart J. 1991, 65, 302-310.
39. P. D. Richardson, M. J. Davies, G. V. Born, Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989, 2, 941-944.
40. M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P. H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P. J. Fitzgerald, D. S. Siscovick, C. L. de Korte, M. Aikawa, K. E. Juhani Airaksinen, G. Assmann, C. R. Becker, J. H. Chesebro, A. Farb, Z. S. Galis, C. Jackson, I. K. Jang, W. Koenig, R. A. Lodder, K. March, J. Demirovic, M. Navab, S. G. Priori, M. D. Rekhter, R. Bahr, S. M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull Jr., R. S. Schwartz, R. Vogel, P. W. Serruys, G. K. Hansson, D. P. Faxon, S. Kaul, H. Drexler, P. Greenland, J. E. Muller, R. Virmani, P. M. Ridker, D. P. Zipes, P. K. Shah, J. T. Willerson, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108, 1664-1672.
41. S. Ojio, H. Takatsu, T. Tanaka, K. Ueno, K. Yokoya, T. Matsubara, T. Suzuki, S. Watanabe, N. Morita, M. Kawasaki, T. Nagano, I. Nishio, K. Sakai, K. Nishigaki, G. Takemura, T. Noda, S. Minatoguchi, H. Fujiwara, Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000, 102, 2063-2069.
42. L. H. Arroyo, R. T. Lee. Mechanisms of plaque rupture: mechanical and biologic interactions. Cardiovasc. Res. 1999, 41, 369-375.
43. L. Petit, P. Lesnik, C. Dachet, M. Moreau, M. J. Chapman, Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: relationship to tissue factor induction by cholesterol and oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 309-315.
44. M. M. Kockx, G. R. De Meyer, N. Buyssens, M. W. Knaapen, H. Bult, A. G. Herman, Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ. Res. 1998, 83, 378-387.
45. A. C. Newby, A. B. Zaltsman, Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 1999, 41, 345-360.
46. P. K. Shah, Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc. Med. 1998, 3, 199-206.
47. P. Libby, Molecular bases of the acute coronary syndromes. Circulation 1995, 91, 2844-2850.
48. M. J. McCarthy, I. M. Loftus, M. M. Thompson, L. Jones, N. J. London, P. R. Bell, A. R. Naylor, N. P. Brindle, Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 1999, 30, 261-268.
49. O. J. de Boer, A. C. van der Wal, P. Teeling, A. E. Becker, Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc. Res. 1999, 41, 443-449.
50. C. M. Ballantyne, Clinical trial endpoints: angiograms, events, and plaque instability. Am. J. Cardiol. 1998, 82, 5M-11M.
51. K. Yokoya, H. Takatsu, T. Suzuki, H. Hosokawa, S. Ojio, T. Matsubara, T. Tanaka, S. Watanabe, N. Morita, K. Nishigaki, G. Takemura, T. Noda, S. Minatoguchi, H. Fujiwara, Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 1999, 100, 903-909.
52. J. A. Ambrose, M. A. Tannenbaum, D. Alexopoulos, C. E. Hjemdahl-Monsen, J. Leavy, M. Weiss, S. Borrico, R. Gorlin, V. Fuster, Angiographic progression of coronary artery disease and the development of myocardial infarction. J. Am. Coll. Cardiol. 1988, 12, 56-62.
53. P. Winter, N. Bansal, Magnetic resonance, general medical. In: Meyers RA, ed. Encyclopedia of Analytical Chemistry: Applications, Theory, and Instrumentation. Chichester; New York: Wiley; 2000:201-236.
54. S. C. Bushong, Magnetic Resonance Imaging: Physical and Biological Principles, 2nd ed. St. Louis: Mosby; 1996.
55. F. H. Epstein, J. R. Brookeman, Physics of MRI - basic principles. In: A. Lardo, Z. Fayad, N. A. F. Chronos, V. Fuster, eds. Cardiovascular magnetic resonance: established and emerging applications. New York: Martin Dunitz; 2003:1-15.
56. R. M. Weisskoff, P. Caravan, MR contrast agent basics. In: A. Lardo, Z. Fayad, N. A. F. Chronos, V. Fuster, eds. Cardiovascular magnetic resonance: established and emerging applications. New York: Martin Dunitz; 2003:17-38.
57. Y. X. Wang, S. M. Hussain, G. P. Krestin, Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 2001, 11, 2319-2331.
58. H. J. Weinmann, W. Ebert, B. Misselwitz, H. Schmitt-Willich, Tissue-specific MR contrast agents. Eur. J. Radiol. 2003, 46, 33-44.
59. J. W. Bulte, I. D. Duncan, J. A. Frank, In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cereb. Blood Flow Metab. 2002, 22, 899-907.
60. S. A. Schmitz, M. Taupitz, S. Wagner, K. J. Wolf, D. Beyersdorff, B. Hamm, Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J. Magn. Reson. Imaging 2001, 14, 355-361.
61. M. E. Kooi, V. C. Cappendijk, K. B. Cleutjens, A. G. Kessels, P. J. Kitslaar, M. Borgers, P. M. Frederik, M. J. Daemen, J. M. van Engelshoven, Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107, 2453-2458.
62. S. A. Schmitz, S. E. Coupland, R. Gust, S. Winterhalter, S. Wagner, M. Kresse, W. Semmler, K. J. Wolf, Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest. Radiol. 2000, 35, 460-471.
63. P. Constantinides, Plaque fissuring in human coronary thrombosis. J. Atheroscler. Res. 1966, 6, 1-17.
64. L. Oltrona, C. M. Speidel, D. Recchia, S. A. Wickline, P. R. Eisenberg, D. R. Abendschein, Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 1997, 96, 646-652.
65. J. S. Kerr, S. A. Mousa, A. M. Slee, amb3-Integrin in angiogenesis and restenosis. Drug News Perspect. 2001, 14, 143-150.
66. G. G. Bishop, J. A. McPherson, J. M. Sanders, S. E. Hesselbacher, M. J. Feldman, C. A. McNamara, L. W. Gimple, E. R. Powers, S. A. Mousa, I. J. Sarembock, Selective amb3-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 2001, 103, 1906-1911.
67. M. H. Corjay, S. M. Diamond, K. L. Schlingmann, S. K. Gibbs, J. K. Stoltenborg, A. L. Racanelli, amb3, amb5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation. J. Cell Biochem. 1999, 75, 492-504.
68. P. C. Brooks, S. Stromblad, R. Klemke, D. Visscher, F. H. Sarkar, D. A. Cheresh, Antiintegrin amb3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 1995, 96, 1815-1822.
69. S. A. Anderson, R. K. Rader, W. F. Westlin, C. Null, D. Jackson, G. M. Lanza, S. A. Wickline, J. J. Kotyk, Magnetic resonance contrast enhancement of neovasculature with amb3-targeted nanoparticles. Magn. Reson. Med. 2000, 44, 433-539.
70. P. M. Winter, S. D. Caruthers, A. Kassner, T. D. Harris, L. K. Chinen, J. S. Allen, E. K. Lacy, H. Zhang, J. D. Robertson, S. A. Wickline, G. M. Lanza, Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel amb3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003, 63, 5838-5843.
71. A. N. Tenaglia, K. G. Peters, M. H. Sketch Jr., B. H. Annex, Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am. Heart J. 1998, 135, 10-14.
72. Y. Zhang,W. J. Cliff, G. I. Schoefl, G. Higgins, Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am. J. Pathol. 1993, 143, 164-172.
73. K. S. Moulton, K. Vakili, D. Zurakowski, M. Soliman, C. Butterfield, E. Sylvin, K. M. Lo, S. Gillies, K. Javaherian, J. Folkman, Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 4736-4741.
74. W. Cacheris, T. Richard, R. Grabiak, A. Lee, Paramagnetic complexes of N-alkyl-N-hydroxylamides of organic acids and emulsions containing same for magnetic resonance imaging. United States: HemaGen/PFC; 1997.
75. C. W. Grant, S. Karlik, E. Florio, A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA. Magn. Reson. Med. 1989, 11, 236-243.
76. A. M. Morawski, P. M. Winter, K. C. Crowder, S. D. Caruthers, R. W. Fuhrhop, M. J. Scott, J. D. Robertson, D. R. Abendschein, G. M. Lanza, S. A. Wickline, Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn. Reson. Med. 2004, 51, 480-486.
77. T. M. Button, R. J. Fiel, Isointense model for the evaluation of tumor-specific MRI contrast agents. Magn. Reson. Imaging 1988, 6, 275-280.
78. E. T. Ahrens, U. Rothbacher, R. E. Jacobs, S. E. Fraser, A model for MRI contrast enhancement using T1 agents. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 8443-8448.
79. D. A. Sipkins, D. A. Cheresh, M. R. Kazemi, L. M. Nevin, M. D. Bednarski, K. C. Li, Detection of tumor angiogenesis in vivo by amb3-targeted magnetic resonance imaging. Nat. Med. 1998, 4, 623-626.
80. D. Artemov, N. Mori, R. Ravi, Z. M. Bhujwalla, Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 2003, 63, 2723-2727.